Benoît You - Publications, H-index & Citations

Benoît You

groupe d'investigateurs national des etudes des cancers ovariens et du sein

47H指数

546论文数

1.1W被引数

收录论文 130

发表时间

Platinum-resistant ovarian cancers: lessons from KEYNOTE-B96 铂耐药性卵巢癌：KEYNOTE-B96的经验教训

The Lancet

IF88.5

2026-09-17

PREAI

Stanislas Quesada; Manuel Rodrigues; Anne-Claire Hardy; Benoît You; Alexandra Leary; Isabelle Ray-Coquard

Response to Correspondence on “Differences in first-line chemosensitivity assessed by KELIM in advanced serous ovarian cancer: evidence from Western and Japanese trials in a Gynecologic Cancer InterGroup (GCIG) Meta-analysis”

International Journal of Gynecological Cancer

IF4.7

2026-07-10

PREAI

Pauline Corbaux; Benoit You

Longitudinal kinetics of human epididymis protein 4 in recurrent advanced ovarian carcinoma treated with platinum-based chemotherapy: mathematical modeling and prognostic implications

International Journal of Gynecological Cancer

IF4.7

2026-07-03

OAAI

Petra Nardelli; Katharina Leitner; Aurore Carrot; Julia Irsara; Julia Jaritz; Julia Schult; Paul Triendl; Simon Schnaiter; Pauline Corbaux; Gilles Freyer; Christian Marth; Heidelinde Fiegl; Benoit You; Olivier Colomban

Differences in First-Line Chemosensitivity Assessed by KELIM in Advanced Serous Ovarian Cancer: Evidence From Western and Japanese Trials in a Gynecologic Cancer InterGroup (GCIG) Meta-analysis KELIM评估的晚期浆液性卵巢癌一线化疗敏感性差异：源自妇科肿瘤协作组（GCIG）荟萃分析的西方与日本试验证据

International Journal of Gynecological Cancer

IF4.7

2026-06-16

PREAI

Pauline Corbaux; Benoit You; Iain McNeish; Stephen Welch; Anna V. Tinker; Mansoor R. Mirza; Kristina Lindemann; Tatsuo Kagimura; Isabelle L. Ray-Coquard; Fabien Subtil; Julien Péron; Karen Carty; Caroline Kelly; Olivier Colomban; Eleni Karamouza; Adrian Cook; Xavier Paoletti; Rosalind M. Glasspool; Nozomu Yanaihara

Molecular Relationship Between Ovarian Sertoli-Leydig Cell Tumors and Their Heterologous Elements 卵巢sertoli-leydig细胞瘤与其异源成分之间的分子关系

AMERICAN JOURNAL OF SURGICAL PATHOLOGY

IF4.2

2026-02-01

PREAI

Trecourt, Alexis; Scard, Clemence; Descotes, Francoise; Lopez, Jonathan; Treilleux, Isabelle; Averous, Gerlinde; Illac-Vauquelin, Claire; Bataillon, Guillaume; Loussouarn, Delphine; Dijoud, Frederique; Ray-Coquard, Isabelle; You, Benoit; Alix, Eudeline; Gertych, Witold; Genestie, Catherine; Devouassoux-Shisheboran, Mojgan

Association between molecular classification and overall survival in patients with metastatic endometrial carcinoma: ancillary results of the UTOLA phase II GINECO trial.转移性子宫内膜癌患者中分子分型与总生存期的关联：UTOLA II期GINECO试验的辅助结果。

International Journal of Gynecological Cancer

IF4.7

2025-11-21

PREAI

Guillaume Beinse; Karen Leroy; Pierre-Alexandre Just; Corinne Jeanne; François Cherifi; Alexandra Leary; Olivia Le Saux; Benoît You; Manuel Rodrigues; Laurence Gladieff; Sophie Abadie-Lacourtoisie; Leïla Bengrine Lefevre; Pierre-Emmanuel Brachet; Coriolan Lebreton; Guillaume Meynard; Pierre Fournel; Jean-Sébastien Frenel; Frédéric Selle; Rémy Largillier; Cyril Foa

Utility of CA125 KELIM in Predicting Benefit from HIPEC in Patients with Advanced Ovarian Cancer: Pooled Analysis of KGOG3042 and KOV-HIPEC-01 CA125 KELIM在预测高级别卵巢癌患者从HIPEC中获益中的效用：KGOG3042和KOV-HIPEC-01的合并分析

International Journal of Gynecological Cancer

IF4.7

2025-10-20

PREAI

Hyun-Woong Cho; Suk-Joon Chang; Myong Cheol Lim; Ji Hyun Kim; Sang-Yoon Park; Jung-Yun Lee; Dong Hoon Suh; Jae-Yun Song; Min Chul Choi; Mi Kyung Kim; Hee-Seung Kim; Aurore Carrot; Benoit You

Identifying High-Risk Relapse in Early-Stage I–II Ovarian Cancer Using the CA-125 ELIMination rate constant K (KELIM) Score: A GCIG Individual Patient Data Meta-analysis 使用CA-125 ELIMination率常数K (KELIM)评分识别早期I-II期卵巢癌的高复发风险：一项GCIG个体患者数据荟萃分析

International Journal of Gynecological Cancer

IF4.7

2025-10-10

OAAI

Pauline Corbaux; Benoit You; Tatsuo Kagimura; Rosalind M. Glasspool; Iain McNeish; Adrian Cook; Mansoor R. Mirza; Kristina Lindemann; Anna V. Tinker; Stephen Welch; Isabelle L. Ray-Coquard; Fabien Subtil; Olivier Colomban; Julien Péron; Eleni Karamouza; Caroline Kelly; Liz-Anne Lewsley; Xavier Paoletti; Nozomu Yanaihara

A randomized, phase III study of sacituzumab govitecan versus treatment of physician’s choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2)一项关于sacituzumab govitecan与医生选择治疗方案在经过铂类化疗和免疫治疗后的子宫内膜癌患者中的随机、III期研究：ASCENT-GYN-01研究（GOG-3104/ENGOT-en26/APGOT-EN2）。

International Journal of Gynecological Cancer

IF4.7

2025-09-07

PREAI

Ramez N. Eskander; Bradley Corr; David Cibula; David S.P. Tan; Noelle Cloven; Eva Guerra; Kosei Hasegawa; Tashanna Myers; Benoit You; Vicky Makker; Flora Zagouri; Lilian T. Gien; Michele Bartoletti; Adrianne Mallen; Linn Woelber; Simonetta Mocci; Kimberly Komatsubara; Long Ma; Nicoletta Colombo

Results of a National French Survey on use of KELIM model for management of patients with advanced stage epithelial ovarian cancer (SFOG Campus)一项关于KELIM模型在晚期上皮性卵巢癌患者管理中应用的国家法国调查结果（SFOG Campus）

BULLETIN DU CANCER

IF0.8

2025-09-01

OAAI

Roufai, Diana Bello; El Hajj, Houssein; Tran, Phuong Lien; Descargues, Pierre; Babin, Guillaume; Lagarde, Sarah Betrian; You, Benoit; Deluche, Elise

Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial 奥拉帕利维持治疗在铂类为基础化疗后的晚期/转移性子宫内膜癌中的应用：GINECO随机IIb期UTOLA试验

Nature Communications

IF15.7

2025-08-26

OAAI

Florence Joly; Alexandra Leary; Isabelle Ray-Coquard; Bernard Asselain; Manuel Rodrigues; Laurence Gladieff; Guillaume Meynard; Sophie Abadie-Lacourtoisie; Coriolan Lebreton; Leïla Bengrine Lefevre; Pierre Fournel; Rémy Largillier; Frédéric Selle; Jean-Sébastian Frenel; Yolanda Fernandez Diez; Cyril Foa; Philippe Follana; Jérôme Meunier; Michel Fabbro; Anne-Claire Hardy Bessard; Isabelle Cojean-Zelek; Emilie Kaczmarek; Elise Bonnet; Antoine Arnaud; Sophie Roche; Karen Leroy; Pierre-Alexandre Just; Raphaël Leman; Corinne Jeanne; Céline Callens; Benoit You; Jérôme Alexandre

Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial 帕博利珠单抗和伏立诺他联合治疗复发性/转移性鳞状细胞癌的疗效：一项II期篮式试验

Nature Cancer

IF28.5

2025-06-30

OAAI

Edith Borcoman; Bastien Cabarrou; Miguel Francisco; Frédéric Bigot; François Ghiringhelli; Damien Vansteene; François Legrand; Maral Halladjian; Célia Dupain; Olivia Le Saux; Clelia Coutzac; Christian Borel; Raphael Chaltiel; Benoit You; Carlos Gomez-Roca; Sophie Cousin; Elodie Coquan; Aurélien Lambert; Esma Saada-Bouzid; Xavier Durando; Mathilde Saint-Ghislain; Gianmaria Frige; Elena Guerini-Rocco; Maria Manuela Tonini; Ivan Bièche; Zahra Castel-Ajgal; Grégoire Marret; Marie-Paule Sablin; Emmanuelle Jeannot; Fabrice Andre; Thomas Filleron; Marta Jimenez; Luca Mazzarella; Nicolas Servant; Maud Kamal; Christophe Le Tourneau

Predictive value of BRCA1/RAD51C methylation in HGSOC – An ancillary study of the PAOLA-1/ENGOT-ov25 phase 3 trial BRCA1/RAD51C甲基化在HGSOC中的预测价值——PAOLA-1/ENGOT-ov25 III期试验的附属研究

European Journal of Cancer

IF7.1

2025-06-03

PREAI

H. Blons; J. Abdelli; S. Landman; V. Taly; C. Mulot; P. Laurent-Puig; B. You; P. Harter; D. Lorusso; Y. García-García; S. Polterauer; S. Hietanen; N. Colombo; I. Vergote; H. Kobayashi; T. De La Motte Rouge; P. Buderath; S.C. Cecere; G. Bataillon; E. Pujade-Lauraine; I. Ray-Coquard

Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin 接受恩沃利单抗 vedotin 治疗的患者中，药物相关皮肤不良事件与生存结局的关联。

EUROPEAN JOURNAL OF CANCER

IF7.1

2025-06-01

OAAI

Belkaid, Samy; Ribereau-Gayon, Emmanuel; Chabaud, Sylvie; Anriot, Julien; Chalas, Thibald; Flechon, Aude; Boyle, Helen; Vinceneux, Armelle; Berard, Frederic; You, Benoit; Freyer, Gilles; Darnis, Sophie; Tartas, Sophie; Amini-Adle, Mona

Impact of adding the immune checkpoint inhibitor atezolizumab to first-line chemotherapy on progression-free survival in poor-prognosis ovarian cancer: A retrospective analysis from the IMagyn050 trial 在预后不良的卵巢癌中，添加免疫检查点抑制剂atezolizumab到一线化疗对无进展生存期的影响：IMagyn050试验的一项回顾性分析

gynecologic oncology

IF4.1

2025-06-01

OAAI

You, Benoit; Anderson, Charles; Cecere, Sabrina Chiara; Carrot, Aurore; Myers, Tashanna; Heitz, Florian; Sharma, Sudarshan; Selcukbiricik, Fatih; Aghajanian, Carol; Fernebro, Josefin; Blank, Stephanie; Laudani, Maria Elena; Thaker, Premal H.; Yunokawa, Mayu; Willmott, Lyndsay; Lisyanskaya, Alla; Hegg, Roberto; He, Yvette; Landen, Charles; Lin, Yvonne G.; Alarcon, Jesus; Moore, Kathleen N.

Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer 关于晚期卵巢癌维持治疗方案选择和护理模式的驱动因素共识

International Journal of Gynecological Cancer

IF4.7

2025-04-19

OAAI

Alejandro Perez-Fidalgo; Barbara Schmalfeldt; Angela George; Charlie Gourley; Sandro Pignata; Domenica Lorusso; Maria Pilar Barretina-Ginesta; Ignacio Romero; Christoph Grimm; Toon Van Gorp; Maria Rossing; Dearbhaile C. Collins; Josefin Fernebro; Line Bjørge; Alexandra Leary; Thibault de la Motte Rouge; Philipp Harter; Christian Kurzeder; Joana Savva-Bordalo; Benoit You

Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery 整合临床-分子数据以预测接受间隔肿瘤细胞减灭术的晚期卵巢癌患者对PARP抑制剂的疗效

gynecologic oncology

IF4.1

2025-04-01

OAAI

Marchetti, Claudia; Ergasti, Raffaella; Capomacchia, Filippo Maria; Giannarelli, Diana; Mastrantoni, Luca; Pepe, Francesco; Apostol, Adriana Ionelia; Sassu, Carolina Maria; Nero, Camilla; Piermattei, Alessia; Zannoni, Gian Franco; Troncone, Giancarlo; Colomban, Olivier; Russo, Gianluca; Carrot, Aurore; Malapelle, Umberto; You, Benoit; Lorusso, Domenica; Scambia, Giovanni; Fagotti, Anna

Patterns of genomic instability in > 2000 patients with ovarian cancer across six clinical trials evaluating olaparib 在评估奥拉帕尼的六项临床试验中，超过2000名卵巢癌患者的基因组不稳定性模式

GENOME MEDICINE

IF11.2

2024-12-18

OAAI

Barnicle, Alan; Ray-Coquard, Isabelle; Rouleau, Etienne; Cadoo, Karen; Simpkins, Fiona; Aghajanian, Carol; Leary, Alexandra; Poveda, Andres; Lheureux, Stephanie; Pujade-Lauraine, Eric; You, Benoit; Ledermann, Jonathan; Matulonis, Ursula; Gourley, Charlie; Timms, Kirsten M.; Lai, Zhongwu; Hodgson, Darren R.; Elks, Cathy E.; Dearden, Simon; Egile, Coumaran; Lao-Sirieix, Pierre; Harrington, Elizabeth A.; Brown, Jessica S.

Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer

BRITISH JOURNAL OF CANCER

IF6.8

2024-11-16

PREAI

Morgan, Robert D.; Wang, Xin; Barnes, Bethany M.; Spurgeon, Laura; Carrot, Aurore; Netto, Daniel; Hasan, Jurjees; Mitchell, Claire; Salih, Zena; Desai, Sudha; Shaw, Joseph; Winter-Roach, Brett; Schlecht, Helene; Burghel, George J.; Clamp, Andrew R.; Edmondson, Richard J.; You, Benoit; Evans, D. Gareth R.; Jayson, Gordon C.; Taylor, Stephen S.

Role of tumor primary chemosensitivity assessed by modeled CA-125 KELIM to predict complete interval debulking surgery (IDS) in ovarian carcinoma patients treated with neo-adjuvant chemotherapy and immunotherapy: A GINEGEPS/GINECO study of the NeoPembrOv and INeOV trials 通过模拟CA-125 KELIM评估肿瘤原发性化疗敏感性，以预测接受新辅助化疗和免疫治疗治疗的卵巢癌患者完全间隔减瘤术（IDS）的作用：一项GINEGEPS/GINECO研究，来自NeoPembrOv和INeOV试验

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Corbaux, P.; Leary, A.; Le Saux, O.; Colomban, O.; Treilleux, I.; Genestie, C.; Chardin, L.; Collet, L.; Lefevre, L. Bengrine; Kuentz, M. Auvray; Martinez, M.; Blonz, C.; Priou, F.; Alexandre, J.; Cloarec, N.; Lebreton, C.; Venat, L.; Savoye, A. M.; You, B.; Ray-Coquard, I. L.

研究方向